<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02380365</url>
  </required_header>
  <id_info>
    <org_study_id>2602-2015</org_study_id>
    <nct_id>NCT02380365</nct_id>
  </id_info>
  <brief_title>QT-Prolongation in Lung Transplantation</brief_title>
  <acronym>TX-QTC</acronym>
  <official_title>QT-Prolongation in Lung Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hannover Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Experimental intervention: electrocardiography. Control intervention: none

      Duration of intervention per patient/subject:

      5 min, observation 6 months

      Key inclusion criteria:

        -  outpatients after lung transplantation (single, double or combined)

        -  outpatients on the wait list for lung transplantation

      Key exclusion criteria:

      • no informed consent
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary endpoint:

      • prevalence of significant QTc-interval prolongation (500 msec or above) after lung
      transplantation

      Key secondary endpoint(s):

        -  prevalence of any QTc-interval prolongation (&gt;440 msec ) after lung transplantation

        -  prevalence of PQ prolongation (200 msec sec or above) after lung transplantation

        -  prevalence of QRS prolongation (120 msec or above) after lung transplantation

        -  prevalence of QTc-prolonging drugs in drug regimen before and after lung transplantation

        -  influence of long-term neo-macrolide (e.g. azithromycin) on QTc interval after lung
           transplantation

        -  intra-individual difference of QTc interval before and after lung transplantation

        -  incidence of any QTc-interval prolongation(&gt;440 msec ) after lung transplantation

        -  incidence of any QTc-interval prolongation (&gt;440 msec or increase by 50msec or above)
           after initiation of new QTc prolonging drugs (especially neo-macrolides)

        -  reversal of QTc-interval prolongation (440 msec or lower or decrease by 50msec or above)
           after stopping any QTc prolonging drug

        -  Assessment of safety:

        -  Incidence of new onset heart rhythm disorder during 6 months of follow-up
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>prevalence of significant QTc-interval prolongation (500 msec or above) after lung transplantation</measure>
    <time_frame>6 month</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">720</enrollment>
  <condition>Disorder Related to Lung Transplantation</condition>
  <arm_group>
    <arm_group_label>Outpatients on the Waiting List and after Lung Transplantation</arm_group_label>
    <description>Electrocardiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrocardiography</intervention_name>
    <description>Duration of intervention per patient/subject:
5 min, observation 6 months</description>
    <arm_group_label>Outpatients on the Waiting List and after Lung Transplantation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Follow-up Patients after lung transplantation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  outpatients after lung transplantation (single, double or combined)

          -  outpatients on the wait list for lung transplantation

        Exclusion Criteria:

          -  no informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Gottlieb, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hannover MS, Dpt Respiratory Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susanne Hoyer, MD</last_name>
    <phone>00495115324601</phone>
    <email>hoyer.susanne@mh-hannover.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jens Gottlieb, MD</last_name>
    <phone>00495115324681</phone>
    <email>gottlieb.jens@mh-hannover.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Respiratory Medicine, Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2015</study_first_submitted>
  <study_first_submitted_qc>March 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2015</study_first_posted>
  <last_update_submitted>March 2, 2015</last_update_submitted>
  <last_update_submitted_qc>March 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lung transplantation</keyword>
  <keyword>electrocardiography</keyword>
  <keyword>macrolides</keyword>
  <keyword>QTc interval</keyword>
  <keyword>arrhythmia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Long QT Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

